Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
Completed · Not applicable
Conditions studied: Depressive Disorder, Major
In brief
This is an 8 week study for patients who are currently taking antidepressant medication but not fully responding. Ropinirole CR would be taken in conjunction with current antidepressant medication. Patients come into the clinic once a week when starting on the medication and then once every other week for the remainder of the 8 weeks.
Key facts
- Study ID
- NCT00285727
- Run by
- Stanford University
- People needed
- 60
- Starts
- 2006-01-01
- Expected to finish
- 2007-10-01
- Last updated by the study team
- 2008-05-19
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 to 65 years old
- Currently experiencing major depression
- On at least an adequate dose of fluoxetine, paroxetine, sertraline, citalopram, escitalopram, venlafaxine, bupropion, mirtazapine or duloxetine for at least 6 weeks (monotherapy). Exclusion Criteria:1. Pregnant females or females of child bearing years not using adequate birth control in the opinion of the investigators
- Known sensitivity to ropinirole
- Significant medical conditions that would preclude safe participation in the study in the opinion of the investigators.
- Significant abnormalities observed in screening laboratory evaluation
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
- Depression Research Clinic, Psychiatry Department, Stanford School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.